Septerna (SEPN) Deferred Taxes (2024)
Septerna (SEPN) posted quarterly Deferred Taxes of -$153000.0 for Q4 2024, down 12.5% quarter-over-quarter from -$136000.0 in Q3 2024.
Septerna (SEPN) Deferred Taxes (2024) Analysis & Trends
Septerna's Deferred Taxes history runs 1 years deep, the most recent figure standing at -$153000.0 for Q4 2024.
- In Q4 2024, Deferred Taxes changed N/A year-over-year to -$153000.0; the TTM figure through Dec 2024 stood at -$491000.0 (changed N/A YoY), while the FY2024 annual figure was -$491000.0, down 200.0% from the prior year.
- Deferred Taxes for Q4 2024 stood at -$153000.0, down from -$136000.0 in the prior quarter.
- The five-year high for Deferred Taxes was -$93000.0 in Q1 2024, with the low at -$153000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Septerna | 2.08 Bn | 2.08 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -153,000.00 |
| Sep 30, 2024 | -136,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Mar 31, 2024 | -93,000.00 |